ATE402140T1 - Cyclopentyl sulfonamid derivaten - Google Patents
Cyclopentyl sulfonamid derivatenInfo
- Publication number
- ATE402140T1 ATE402140T1 AT00978244T AT00978244T ATE402140T1 AT E402140 T1 ATE402140 T1 AT E402140T1 AT 00978244 T AT00978244 T AT 00978244T AT 00978244 T AT00978244 T AT 00978244T AT E402140 T1 ATE402140 T1 AT E402140T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfonamide derivatives
- cyclopentyl sulfonamide
- cyclopentyl
- mammal
- useful
- Prior art date
Links
- OPASRWWZEIMSOZ-UHFFFAOYSA-N cyclopentanesulfonamide Chemical class NS(=O)(=O)C1CCCC1 OPASRWWZEIMSOZ-UHFFFAOYSA-N 0.000 title abstract 3
- 102000018899 Glutamate Receptors Human genes 0.000 abstract 1
- 108010027915 Glutamate Receptors Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16968499P | 1999-12-08 | 1999-12-08 | |
| US21428300P | 2000-06-26 | 2000-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402140T1 true ATE402140T1 (de) | 2008-08-15 |
Family
ID=26865281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00978244T ATE402140T1 (de) | 1999-12-08 | 2000-11-03 | Cyclopentyl sulfonamid derivaten |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1246797B1 (de) |
| AT (1) | ATE402140T1 (de) |
| AU (1) | AU1572301A (de) |
| DE (1) | DE60039631D1 (de) |
| ES (1) | ES2307537T3 (de) |
| WO (1) | WO2001042203A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6900353B2 (en) | 2000-10-13 | 2005-05-31 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
| CA2446161A1 (en) * | 2001-05-04 | 2002-11-14 | Emanuele Sher | Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes |
| GB0417709D0 (en) * | 2004-08-09 | 2004-09-08 | Glaxo Group Ltd | Compounds |
| US7411093B2 (en) | 2004-12-20 | 2008-08-12 | Hoffman-La Roche Inc. | Aminocycloalkanes as DPP-IV inhibitors |
| DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
| JP5014334B2 (ja) * | 2005-10-06 | 2012-08-29 | イーライ リリー アンド カンパニー | Ａｍｐａ受容体増強剤 |
| GB0602560D0 (en) * | 2006-02-08 | 2006-03-22 | Glaxo Group Ltd | Compounds |
| US20090221643A1 (en) * | 2006-02-08 | 2009-09-03 | Kevin Michael Thewlis | 4-phenyl-3-(2-propylsulfonylamino) tetrahydrofuran derivatives which potentiate glutamate receptors and are useful in the treatment of schizophrenia |
| CA2688493C (en) | 2007-05-31 | 2016-04-19 | Sepracor Inc. | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
| EP2554163A4 (de) * | 2010-03-26 | 2013-07-17 | Univ Hokkaido Nat Univ Corp | Therapeutischer wirkstoff für neurodegenerative erkrankungen |
| WO2014201411A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
| WO2018009256A1 (en) | 2016-03-29 | 2018-01-11 | Respirerx Pharmaceuticals, Inc. | Compositions and methods for treating attention deficit disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| AU741742B2 (en) * | 1998-02-24 | 2001-12-06 | Eli Lilly And Company | Sulphonamide derivatives |
-
2000
- 2000-11-03 AT AT00978244T patent/ATE402140T1/de not_active IP Right Cessation
- 2000-11-03 AU AU15723/01A patent/AU1572301A/en not_active Abandoned
- 2000-11-03 WO PCT/US2000/028878 patent/WO2001042203A1/en not_active Ceased
- 2000-11-03 DE DE60039631T patent/DE60039631D1/de not_active Expired - Lifetime
- 2000-11-03 ES ES00978244T patent/ES2307537T3/es not_active Expired - Lifetime
- 2000-11-03 EP EP00978244A patent/EP1246797B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1246797B1 (de) | 2008-07-23 |
| ES2307537T3 (es) | 2008-12-01 |
| AU1572301A (en) | 2001-06-18 |
| WO2001042203A1 (en) | 2001-06-14 |
| DE60039631D1 (de) | 2008-09-04 |
| EP1246797A1 (de) | 2002-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
| NL300877I2 (nl) | obeticholzuur | |
| BG66085B1 (bg) | Фенилаланинови производни | |
| ATE297910T1 (de) | Retinoid x rezeptormodulatoren | |
| SE9904505D0 (sv) | Novel compounds | |
| BG107171A (bg) | Производни на пурин | |
| TR200402656T4 (tr) | Antikanser ajanları olarak faydalı tiyofen türevleri | |
| TR200102338T2 (tr) | Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar. | |
| DE60039631D1 (de) | Cyclopentyl sulfonamid derivaten | |
| BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
| TR200101663T2 (tr) | Pro-kollajen c-proteinaz inhibitörleri | |
| ATE345349T1 (de) | Purinderivate | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| ATE266400T1 (de) | Heterocyclyl sulphonamid derivate | |
| EP0980864A3 (de) | Sulfonamid-Derivate | |
| TR200200125T2 (tr) | Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar. | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| DK0937708T3 (da) | Sulfonamidderivater | |
| TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
| MXPA04003297A (es) | Derivados novedosos de benzotiacina su preparacion y uso. | |
| TR200002293T2 (tr) | Farmasötik bileşimler. | |
| CY1105798T1 (el) | Στepοειδη, η παρασκευη τους, φαρμακευτικες συνθεσεις απο αυτα και χρησεις των ενωσεων | |
| ATE213236T1 (de) | Substituierte benzyloxyimino-verbindungen | |
| PT1104419E (pt) | Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao | |
| SE9803107D0 (sv) | Novel Compunds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |